Single Intramuscular Dose Of Anthim Is More Effective Than Daily Dosing Of Antibiotics Against A Lethal Anthrax Spore Challenge

... Today, at the 4th Annual AmericanSociety of Microbiology Biodefense Research Conference in Washington DC,Elusys Therapeutics presented new efficacy data on its anthrax therapeutic,Anthim(TM). The presentation (#69D Posterboard 50) entitled, "IntramuscularAdministration of Anthim, a High-Affinity, Anti-Protective Antigen MAb,Enhances Post-Exposure Antibiotic Efficacy Against Lethal B... click link for more info. ...